You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 24, 2025

Patent: 10,018,625


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,018,625
Title:Use of female mammal\'s urine for determination of fetal gender related characteristics
Abstract: The present invention provides a method for determining the gender of a fetus by assaying the sex hormones, evaluating the overall reducing/oxidizing (redox) activity, and/or evaluating the radical scavenging capacity of the maternal urine or other body fluid. The method can be used to determine fetal gender at any time point during the entire pregnancy. The body fluid may be processed before assaying. Processing may involve aging the body fluid, or purification of various fractions. The methods of the present invention also provide for a means for pre-conception offspring gender planning by assaying the sex hormones, evaluating the overall reducing/oxidizing (redox) activity, and/or evaluating the radical scavenging capacity of the urine or other body fluid from a non-pregnant female. The sex hormone profiles, the overall redox activity, and/or the radical scavenging capacity of a urine sample correlates with the gender specific compatibility of the ovum being released during a particular menstrual cycle. Therefore, assaying aforementioned parameters from a non-pregnant female\'s urine will help a couple or an animal breeder have an offspring of a desired gender. The present invention also provides a method of conceiving a baby of a desired gender in a female by applying to the female a pharmaceutical formulation with a specific sex hormone composition.
Inventor(s): Verma; Kuldeep C. (Livonia, MI)
Assignee: Urobiologics LLC (Livonia, MI)
Application Number:14/312,534
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Patent Landscape: A Comprehensive Analysis of United States Patent 10,018,625

Introduction

Patent law in the United States is a complex and multifaceted field, crucial for protecting inventors and their innovations. The Patent Trial and Appeal Board (PTAB) and various other mechanisms play significant roles in the patent landscape. This article will delve into the specifics of United States Patent 10,018,625, examining the claims, the broader patent landscape, and the relevant legal and procedural aspects.

The Role of the USPTO

The U.S. Patent and Trademark Office (USPTO) is the federal agency responsible for reviewing patent applications and granting patents. The USPTO ensures that patents meet specific requirements, including eligibility subject matter, novelty, and nonobviousness[1][5].

Eligible Subject Matter Requirement

For a patent to be granted, the invention must fall within the eligible subject matter as defined by the Patent Act. This includes "any new and useful process, machine, manufacture, or composition of matter, or any improvement thereof." However, laws of nature, natural phenomena, and abstract ideas are not patentable. The Supreme Court's Alice/Mayo framework provides a two-step test to determine if a patent claim is directed to ineligible subject matter and whether it contains an inventive concept[1].

Novelty Requirement

The claimed invention must be novel, meaning it must not have been patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. If every element of the claimed invention is already disclosed in the prior art, no valid patent can be issued[1].

Nonobviousness Requirement

Even if an invention is novel, it must also be nonobvious. This means that the invention must be significantly different from existing technology and not obvious to a person of ordinary skill in the relevant field. The USPTO and courts use various tests to determine nonobviousness[1].

The Patent Trial and Appeal Board (PTAB)

The PTAB, established by the Leahy-Smith America Invents Act (AIA) in 2011, is a tribunal within the USPTO that hears administrative challenges to the validity of patents. PTAB administers proceedings such as Inter Partes Review (IPR) and Post-Grant Review (PGR), where petitioners can seek to invalidate a patent on grounds that it fails to meet the patentability requirements[1].

Patent Security Reviews

In addition to the standard patentability requirements, certain inventions may undergo security reviews to ensure that their disclosure or publication does not compromise national security. The Invention Secrecy Act of 1951 mandates these reviews, and the USPTO works with various defense agencies to impose Secrecy Orders if necessary[2].

Patent Assertion Entities (PAEs)

PAEs, often referred to as "patent trolls," play a significant role in the patent landscape. They acquire and assert patents, often through litigation. The FTC has identified two main types of PAEs: Portfolio PAEs, which negotiate licenses for large portfolios of patents, and Litigation PAEs, which typically sue potential licensees and settle for relatively low royalties. PAEs often target a broad range of industries, including retail and technology sectors[3].

United States Patent 10,018,625: A Case Study

Background

To analyze the claims of United States Patent 10,018,625, one must first understand the context in which it was granted. This involves reviewing the patent application process, the technology area it pertains to, and any potential challenges it may have faced.

Claims Analysis

  • Subject Matter Eligibility: The patent must comply with the eligible subject matter requirements. If the patent claims are directed to laws of nature, natural phenomena, or abstract ideas, they must contain an inventive concept to be patentable.
  • Novelty and Nonobviousness: The claims must be novel and nonobvious. This involves a thorough review of prior art to ensure that the invention is new and not obvious to a person of ordinary skill in the field.
  • Specific Claims: Each claim in the patent must be carefully examined to ensure it meets the patentability requirements. This includes analyzing the language and scope of the claims to determine their validity.

Technological Area

Understanding the technological area of the patent is crucial. For example, if the patent pertains to electrical engineering or software, it would fall under one of the 35 International Patent Classification (IPC) technical fields. The USPTO's data shows that electrical engineering and software-related patents have seen significant growth in recent years[4].

Potential Challenges

The patent could face challenges through PTAB proceedings such as IPR or PGR. Petitioners might argue that the patent fails to meet the novelty or nonobviousness requirements, or that it is directed to ineligible subject matter.

Impact on the Patent Landscape

Innovation and Competition

Patents like 10,018,625 can significantly impact innovation and competition within their respective industries. By granting exclusive rights to the patent holder, they can deter others from using the patented invention, which can both promote and hinder innovation depending on how the patent is enforced.

Litigation and PAEs

The presence of PAEs can affect how patents are asserted and litigated. If a patent like 10,018,625 is acquired by a PAE, it could be asserted in a manner that is more aggressive or opportunistic, potentially stifling innovation rather than promoting it[3].

National Security Implications

If the patent involves technology with potential national security implications, it may undergo a security review. This could result in a Secrecy Order, preventing the disclosure or publication of the patent to protect national security interests[2].

International Collaboration

Patents can also be part of international agreements and collaborations. For instance, the NATO Agreement for the Mutual Safeguarding of Secrecy of Inventions allows for the reciprocal filing of classified patent applications, facilitating international collaboration in defense-related technologies[2].

Key Takeaways

  • Patentability Requirements: Patents must meet specific requirements including eligible subject matter, novelty, and nonobviousness.
  • PTAB and Administrative Challenges: The PTAB plays a crucial role in reviewing the validity of patents through administrative proceedings.
  • PAEs and Litigation: PAEs can significantly impact how patents are asserted and litigated, affecting innovation and competition.
  • National Security: Patents with national security implications may be subject to security reviews and Secrecy Orders.
  • International Collaboration: Patents can be part of international agreements, facilitating collaboration in various technological fields.

FAQs

What is the role of the USPTO in the patent process?

The USPTO is responsible for reviewing patent applications, granting patents, and ensuring that patents meet the patentability requirements.

How does the PTAB impact patent validity?

The PTAB administers proceedings such as IPR and PGR, allowing petitioners to challenge the validity of patents on grounds that they fail to meet the patentability requirements.

What are Patent Assertion Entities (PAEs), and how do they affect the patent landscape?

PAEs acquire and assert patents, often through litigation. They can be categorized into Portfolio PAEs and Litigation PAEs, each with different business models that impact innovation and competition.

Can patents be kept secret for national security reasons?

Yes, under the Invention Secrecy Act of 1951, patents that could compromise national security may be subject to Secrecy Orders, preventing their disclosure or publication.

How do international agreements affect patent filings?

International agreements like the NATO Agreement for the Mutual Safeguarding of Secrecy of Inventions allow for the reciprocal filing of classified patent applications, facilitating international collaboration in defense-related technologies.

Sources

  1. Congressional Research Service, "The Patent Trial and Appeal Board and Inter Partes Review," Updated May 28, 2024.
  2. Defense Technology Security Administration, "Patent Security Reviews."
  3. Federal Trade Commission, "Patent Assertion Entity Activity: An FTC Study."
  4. National Center for Science and Engineering Statistics, "Invention: U.S. and Comparative Global Trends."
  5. American Public University, "What Is a Patent Law - And Why Does It Matter?"

More… ↓

⤷  Try for Free

Details for Patent 10,018,625

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 January 15, 1974 10,018,625 2028-03-11
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 December 27, 1984 10,018,625 2028-03-11
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 February 15, 1985 10,018,625 2028-03-11
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 February 16, 1990 10,018,625 2028-03-11
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.